Praxis Biologics
Executive Summary
Licenses patent from University of Rochester for the production and application of human monoclonal antibodies that can neutralize Gram-negative bacteria toxins. "Praxis expects to enter into negotiating multiple, non-exclusive sublicense agreements for the patented technology".